Biocept reaches COVID-19 testing milestone

By staff writers

October 6, 2020 -- Biocept said that it has received more than 50,000 COVID-19 specimens for processing at its molecular laboratory.

What's more, the results for the vast majority of these COVID-19 tests have been reported back to healthcare providers within 48 hours, according to the firm.

In other Biocept news, the company said that it's making progress with its internally developed COVID-19 specimen collection kits. A contract research organization has verified the viricidal effects of the specimen collection tube used for shipping patient samples, Biocept said.

After further validation of the specimen collection kit has been completed at Biocept's lab, it will then be submitted to the U.S. Food and Drug Administration for emergency use authorization, according to the vendor. Biocept said it hopes that the specimen collection kits will be launched later this year for use in its lab and potentially for sales to other labs.

Biocept releases 10K nasal collection kits
Biocept is making 10,000 nasopharyngeal specimen collection kits available for reverse transcription polymerase chain reaction (RT-PCR) testing for the...
Biocept launches molecular assay for BRAF mutations
Bicept has launched a molecular assay kit for the detection of BRAF mutations, which are commonly targeted in the treatment of solid tumors.
Biocept brings EGFR molecular assay kit to Europe
Biocept has received the European CE-IVD Mark for its Target Selector EGFR molecular assay kit and launched the product in Europe.
Biocept launches new line of molecular assay kits
Biocept has launched a new line of research-use-only molecular assay kits for the detection of oncogene mutations.
Biocept to accept COVID-19 test orders in April
Biocept has verified its COVID-19 molecular diagnostic test and plans to begin accepting requests for the processing of tests ordered by physicians starting...

Copyright © 2020

Last Updated ls 10/6/2020 3:14:40 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current